Cover
Vol. 2 No. 2 (2024)

Published: August 31, 2024

Pages: 29-44

Original Article

Exploring the relationship between medication adherence and hospitalization rate in patients with type 2 diabetes mellitus

Sarah Haider Khalid 1 Zahraa Thabit Abd Ali 2 Taemaa Omran Taleb 1 Ruqaia Qasim Hassan 1 Fatima Al Zahraa Mohammad Hadi 1 Mustafa Louay Hamied 1 Ali Ahmed Shaker 1
1Department of Pharmacology and Toxicology, College of pharmacy, Al-Nahrain University, Baghdad, Iraq
2Students of Pharmacy College, Al-Nahrain University, Baghdad, Iraq
History
  • Received: June 30, 2024
  • Available Online: August 31, 2024

Abstract

Medication adherence is defined by the World Health Organization (WHO) as "the degree to which the person‟s behavior corresponds with the agreed recommendations from a health care provider, Adherence to therapies is a primary determinant of treatment success. The aim of the current study to compute the level of medication adherence in hospitalized and non hospitalized patients in order to compare between them and demonstrate the effect of non adherence on hospitalization rate. Sixty patients were participating in the current study (30 hospitalized, 30 non hospitalized) with age ≥ 18 years old, using morisky questionnaire and general questionnaire to collect information that relate to the patient lifestyle, diet, age, sex etc. It was found that 60% of hospitalized patients involved in the study had low adherents, 26.6% medium and only 13.3% were high adherents compared to non hospitalized with 33.3% being high adherents, 33.3% low and medium adherents, and the direct relationship between decreased adherence and increased hospitalization rates, also noticed the effects of age, complexity of treatment, patient provider interactions and unwanted side effects of medications on the rates of adherence. The study found that low adherence was higher in hospitalized patients; the rate of high adherence was increased in non hospitalized patients. Adherence to prescriptions is linked to age, patients' beliefs, education about their health, their trust in health care workers.

Keywords

References

  1. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. In: Diabetes: An Old Disease, A New Insight. 2013;1–11.
  2. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Medicine. 1994;11(3):253–261.
  3. Trevor AJ, Katzung BG, Masters SB, Kruidering-Hall M. Pharmacology Examination & Board Review. New York: McGraw-Hill Medical; 2010. pp. 121–132.
  4. Ralston SH, Penman ID, Strachan MW, Hobson R (Eds.). Davidson's Principles and Practice of Medicine E-Book. Elsevier Health Sciences; 2018.
  5. Howland RD, Mycek MJ, Harvey RA, Champe PC. Lippincott's Illustrated Reviews: Pharmacology. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 103–57.
  6. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (Eds.). Pharmacotherapy: A Pathophysiologic Approach. 2021.
  7. Steiner JF, Earnest MA. The language of medication-taking. Annals of Internal Medicine. 2000;132(11):926–930.
  8. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–467.
  9. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–2883.
  10. Burnier M. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Pressure Monitoring. 2000;5:S31–S34.
  11. Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, et al. How well do clinicians estimate patients’ adherence to combination antiretroviral therapy? Journal of General Internal Medicine. 2002;17:1–11.
  12. Murri R, Ammassari A, Trotta MP, De Luca A, Melzi S, Minardi C, & AdICoNA Study Group. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. Journal of General Internal Medicine. 2004;19:1104–1110.
  13. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M, & VACS 3 Project Team. Patient-and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. Journal of Clinical Epidemiology. 2001;54(12):S91–S98.
  14. Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS One. 2016;11(7):e0158499.
  15. Rassool GH. Failure to take prescribed medicine for chronic diseases is a massive world-wide problem. Journal of Advanced Nursing. 2004;45(4):447–447.
  16. Pednekar P, Heller DA, Peterson AM. Association of medication adherence with hospital utilization and costs among elderly with diabetes enrolled in a state pharmaceutical assistance program. Journal of Managed Care & Specialty Pharmacy. 2020;26(9):1099–1108.
  17. Gold PE, Korol DL. Forgetfulness during aging: an integrated biology. Neurobiol Learn Mem. 2014;112:130–8.
  18. Grant RW, Pirraglia PA, Meigs JB, Singer DE. Trends in complexity of diabetes care in the United States from 1991 to 2000. Archives of Internal Medicine. 2004;164(10):1134–1139.
  19. Ingelsson E, McCarthy MI. Human genetics of obesity and type 2 diabetes mellitus: past, present, and future. Circulation: Genomic and Precision Medicine. 2018;11(6):e002090.
  20. Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Research and Clinical Practice. 2010;87(2):204–210.
  21. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine. 2012;366(17):1577–1585.
  22. Wen CP, Wai JPM, Tsai MK, Yang YC, Cheng TYD, Lee MC, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. The Lancet. 2011;378(9798):1244–1253.
  23. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346(6):393–403.
  24. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet. 2009;374(9702):1677–1686.
  25. World Health Organization. WHO Global Report on Diabetes; 2016.
  26. Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790–1799.